A World That Repeats the Same Failures
Global R&D spending exceeds over $2 trillion a year.
How much of that money is being spent unknowingly repeating experiments someone else has already failed at?
Success becomes papers, blog posts, and conference talks. But failure? It dies in personal notebooks. It gets buried in lab drawers. It stays locked inside pharmaceutical company internal reports.
A researcher on the other side of the planet, holding the same hypothesis, has no way of knowing about that failure. So they spend the same money, burn the same time, and arrive at the same conclusion.
Humanity is groping in the dark, each of us bumping into the same walls.
Failure Is Not a Sunk Cost
It starts with two questions.
- Given the countless failures in the world, is it possible that none of them are duplicates?
- Can failure create value?
The answer to both is yes.
Failure never lacked the ability to create value. The problem was that the cost of structuring it was too high.
“I tried it and it didn’t work” is bar talk. But “under this hypothesis, in these conditions, it failed for this reason” is a searchable, priceable asset. The difference lies in structuring.
Until now, that structuring was prohibitively expensive. Asking someone who has already failed to organize their failure is like asking someone who has already lost money to pay more. Who would do that?
LLMs have dramatically lowered this cost. Talk through a failure experience, and the machine extracts and classifies the hypothesis, conditions, and causes. The cost of structuring has entered the realm of business viability.
For the first time, failure becomes a tradeable asset.
The Blank Spots Are the Opportunity
As failure data accumulates, a map emerges.
The more the areas labeled “tried here, didn’t work” get filled in, the sharper the “blank spots no one has tried yet” become. Those blank spots are the opportunity.
Think about patent searches. Inventors search patent databases to avoid reinventing what already exists. Searching for “what’s already been tried” to avoid duplication. This demand pattern applies equally to failure.
There is one difference. Patent databases record successes; failure maps record failures. If the map of success tells you “don’t bother,” the map of failure tells you “look here.”
As the failure map grows more precise, the boundaries of the blank spots become clearer. As the boundaries sharpen, more people jump into exploration. As more explorers join, failure data accumulates faster, and the map grows even more precise.
Acceleration kicks in.
Professional Failers
In conventional R&D, failure is pure cost.
Try ten times, fail nine, and you lose nine attempts’ worth of budget. That is why only the well-capitalized could afford to try often. The more you try, the higher the probability of success. This was capital’s moat.
In a world where failure is traded, this structure flips.
Each of those nine failures generates revenue. Failure-sale income funds the next experiment. Instead of poking randomly, you pick blank spots on the failure map. Trial count goes up, and trial precision goes up too.
A new profession is born here: the professional failer.
A person who survives on failure, precisely explores blank spots, and maximizes the number of trials. Success is a probability game. The one who tries the most, and most accurately, wins. The professional failer is exactly that person.
A professional failer is simultaneously a failure specialist and the best-positioned aspiring success story.
The Moat of the Giants Crumbles
On average, it takes 10 to 15 years and $2 to 3 billion to bring a single new drug to market. The success rate is below 10%. The failure data from the other 90% stays buried inside big pharma.
That accumulated failure data was the giants’ moat. “We know what doesn’t work. You don’t.”
As AI lowers the barrier to entry for research, individual researchers and small pharma companies are springing up everywhere. When they meet on a platform where failure can be bought and sold, small researchers worldwide effectively function as a single distributed R&D network.
The moat that the giants built with capital — the advantage of internally accumulated failure data — gets democratized by the platform.
Three Wheels Spin at Once
When AI replaces existing jobs, workers are freed up. Simultaneously, AI lowers the barrier to entry for research. But in a world where “fail and you’re done,” freed-up workers struggle to jump into research.
The moment failure becomes an asset, this loop connects.
The investor’s calculus changes too. Traditional R&D investment was all-or-nothing: success or total loss. If failure data can be sold to recoup some of the investment, the worst-case scenario changes. Capital flows into areas that were previously too risky to touch.
Three wheels spin at once.
Labor — Transition from AI-displaced workers to researchers. Survival is possible even in failure. Explorers multiply.
Capital — As failure risk decreases, investment increases. More experiments become possible.
Data — As experiments increase, the failure map grows more precise. As blank spots sharpen, the probability of success rises. More investment and talent flow in.
Only Structured Failure Works
One warning is necessary.
Sharing raw failure is dangerous. Information like “this doesn’t work” alone provides no context. Experimental conditions must be specific enough to distinguish “the same experiment” from “a different experiment.” Only then can duplication be eliminated without discouraging exploration.
In 2002, there was a journal called Journal of Negative Results in Biomedicine. It published papers on failed experiments. It shut down after 15 years. Free, unstructured data attracted no economic incentive.
The lesson is clear. Goodwill alone is not enough. Failure must be structured, and structuring must be economically rewarded. The person who sells failure must earn money so that more failures get structured. More structured failures make the map more precise. A more precise map reduces duplication.
Incentives, not goodwill, drive the system.
Turn On the Light
Until now, humanity has been groping individually in the dark, hitting the same walls over and over.
Turning failure into an asset means turning on the light. It means making visible where people have collided and with what. When the walls are visible, you can go around them. When an open path is visible, you can run toward it.
When failure in one field narrows the blank spots in another, and failure maps connect across domains, humanity’s rate of exploration accelerates exponentially.
Failure is not the end. Failure is the next person’s starting point.